ESC 365 - EMAP II reduces arterial stiffness and end-diastolic myocardial stiffness in hypertension and diabetes

HFA Premium Access

EMAP II reduces arterial stiffness and end-diastolic myocardial stiffness in hypertension and diabetes

Session: Poster Session 2 - Basic Science: Hypertension / LV hypertrophy / Renal denervation

Topic: Hypertension / LV hypertrophy

Speaker: Assistant Professor N. Dorofeyeva (Kiev, UA)

Event: HEART FAILURE 2016

Congress Presentation

Add to my library

About the speaker

Assistant Professor Natalya Dorofeyeva

Bogomoletz Institute of Physiology, Kiev (Ukraine)

0 follower

5 more presentations in this session

Inhibition of long noncoding RNA Chast prevents pressure-overload induced cardiac hypertrophy

Pivotal role of regulator of G-protein signaling 12 in pathological cardiac hypertrophy

Cardiovascular remodelling in L-NAME-induced hypertension: effect of ivabradine

Speaker: Professor F. Simko (Bratislava, SK)

Early diagnostic and correction of syndrome cognitive impairments in arterial hypertension in family doctor practice

Speaker: Doctor V. Krotova (Dnipro, UA)

Hypertension patients: the cerebral circulation and impairment of cognitive functions

Speaker: Doctor O. Soya (Dnipropetrovsk, UA)

Access the full session

Poster Session 2 - Basic Science: Hypertension / LV hypertrophy / Renal denervation

Speakers: Assistant Professor N. Dorofeyeva, Professor F. Simko, Doctor V. Krotova, Doctor O. Soya

About the event

HEART FAILURE 2016

21 May - 24 May 2016

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources